Feed HTSUF
HT
Hisamitsu Pharmaceutical Co., Inc. HTSUF · OTC
$29.00 +0.00% (+$0.00)
Depth
- Market cap
- ¥325.1B
- Enterprise value
- ¥218.3B
- P/E
- 18.5x
- Forward P/E
- -
- PEG
- -
- P/S
- 2.5x
- P/FCF
- -
- EV/EBITDA
- 15.1x
- ROIC
- 4.0%
- Gross margin
- 57.0%
- Net margin
- 14.0%
- Dividend yield
- 2.84%
- Payout ratio
- 51.4%
- Net debt/EBITDA
- -7.4x
- Beta
- 0.29
- Free float
- 43.0%
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kazuhide Nakatomi
Employees
2,759
Headquarters
Tosu
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Earnings per share grew by 17% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 JPY of revenue, 14 JPY is left as net profit.
- What to watch: It earns only 4.0 JPY a year on every 100 JPY of invested capital.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: ¥109.2B against ¥2.38B.
Capital and dividends
What does the company do with the money it earns?
- What speaks for it: It bought back its own shares for ¥12.3B in the last fiscal year, 3.8% of its market value.
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number